parthenolide and Endotoxin Shock

parthenolide has been researched along with Endotoxin Shock in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, X; Eichacker, PQ; Fitz, Y; Hsu, L; Li, X; Li, Y	1
Hake, PW; Malhotra, V; O'Connor, M; Sheehan, M; Wong, HR; Zingarelli, B	1

Other Studies

2 other study(ies) available for parthenolide and Endotoxin Shock

Article	Year
Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice. Cytokine, 2006, Mar-21, Volume: 33, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cytokines; Disease Models, Animal; Lipopolysaccharides; Mice; Mice, Inbred C57BL; NF-kappa B; Sesquiterpenes; Shock, Septic; Signal Transduction; Survival Rate	2006
Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Molecular pharmacology, 2002, Volume: 61, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Disease Models, Animal; DNA; DNA-Binding Proteins; Endotoxins; Enzyme Activation; Hypertension; I-kappa B Proteins; Lung; Male; Neutrophils; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrates; Nitric Oxide; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Sesquiterpenes; Shock, Septic; Tyrosine	2002

Article

Year

Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice.

Cytokine, 2006, Mar-21, Volume: 33, Issue:6

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cytokines; Disease Models, Animal; Lipopolysaccharides; Mice; Mice, Inbred C57BL; NF-kappa B; Sesquiterpenes; Shock, Septic; Signal Transduction; Survival Rate

2006

Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents.

Molecular pharmacology, 2002, Volume: 61, Issue:5

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Disease Models, Animal; DNA; DNA-Binding Proteins; Endotoxins; Enzyme Activation; Hypertension; I-kappa B Proteins; Lung; Male; Neutrophils; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrates; Nitric Oxide; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Sesquiterpenes; Shock, Septic; Tyrosine

2002